Our aim was to assess changes in attitudes to autologous transfusion amongs
t surgeons over a 10-year period in response to scientific evidence, public
awareness, published guidelines, management and the increasing cost of blo
od products.
Surgeons across the north-west of England completed questionnaires on knowl
edge, experience and attitude towards autologous transfusion in 1990, 1994
and 1999.
Main outcome measures were changes in knowledge, experience and utilization
of autologous transfusion; perceived advantages of autologous transfusion,
obstacles to its implementation in surgical practice and preferences for s
pecific techniques (preoperative autologous donation, acute normovolaemic h
aemodilution, intraoperative and postoperative cell salvage).
There has been We change in practice over 10 years. Many more surgeons were
keen to employ autologous transfusion than were using it. Autologous trans
fusion was only used in general, orthopaedic and cardiothoracic surgery. Sa
fety and patient preference were the main arguments for implementation and
logistics the main obstacles.
Autologous transfusion was used sporadically in surgical practice. Clinical
trials are needed to guide clinicians in the choice of transfusion techniq
ues.